1329PEfficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy.

Autor: Cubero, J Hernando¹ (AUTHOR), Grande, E² (AUTHOR), Fonseca, P Jimenez³ (AUTHOR), Villabona, C⁴ (AUTHOR), Perez, J M Trigo⁵ (AUTHOR), Trufero, J Martinez⁶ (AUTHOR), Bernad, I Pajares⁷ (AUTHOR), Lopez, C⁸ (AUTHOR), Alonso, T⁹ (AUTHOR), Biarnes, J¹⁰ (AUTHOR)

Publikováno v: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.